Recursion Pharmaceuticals Inc (RXRX): A Great Stock For Handling Current Market Conditions?
Currently, there are 226.26M common shares owned by the public and among those 215.42M shares have been available to trade. The company’s stock has a 5-day price change of -23.07% and -29.34% over the past three months. RXRX shares are trading -38.44% year to date (YTD), with the 12-month market performance down to -30.23% lower. […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Hogging The Spotlight Today
Currently, there are 226.26M common shares owned by the public and among those 215.45M shares have been available to trade. The company’s stock has a 5-day price change of 6.28% and -15.35% over the past three months. RXRX shares are trading -22.82% year to date (YTD), with the 12-month market performance down to -10.79% lower. […]
Do Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Fit In A Value Investing Philosophy?
Currently, there are 226.26M common shares owned by the public and among those 215.21M shares have been available to trade. The company’s stock has a 5-day price change of 9.48% and -26.79% over the past three months. RXRX shares are trading -27.38% year to date (YTD), with the 12-month market performance down to -16.55% lower. […]
Look At Analyst Expectations For A Better Read On Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Currently, there are 226.26M common shares owned by the public and among those 215.35M shares have been available to trade. The company’s stock has a 5-day price change of -10.40% and -27.20% over the past three months. RXRX shares are trading -36.21% year to date (YTD), with the 12-month market performance down to -42.66% lower. […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Is Getting Increasingly Hard To Ignore
Currently, there are 226.26M common shares owned by the public and among those 204.85M shares have been available to trade. The company’s stock has a 5-day price change of -15.60% and -24.94% over the past three months. RXRX shares are trading -31.95% year to date (YTD), with the 12-month market performance down to -45.89% lower. […]
Is Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Proving The Doubters Wrong?
Recursion Pharmaceuticals Inc (RXRX) concluded trading on Wednesday at a closing price of $8.20, with 4.95 million shares of worth about $40.55 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -16.67% during that period and on July 31, 2024 the price saw a […]
Analyst Expect Big Moves From Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Currently, there are 226.26M common shares owned by the public and among those 198.83M shares have been available to trade. The company’s stock has a 5-day price change of -0.23% and 12.89% over the past three months. RXRX shares are trading -12.98% year to date (YTD), with the 12-month market performance down to -44.54% lower. […]
Uncovering Institutional Buying In Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Currently, there are 226.26M common shares owned by the public and among those 198.88M shares have been available to trade. The company’s stock has a 5-day price change of 14.21% and -6.28% over the past three months. RXRX shares are trading -15.21% year to date (YTD), with the 12-month market performance down to -30.79% lower. […]
Handle With Care: Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Currently, there are 226.26M common shares owned by the public and among those 192.35M shares have been available to trade. The company’s stock has a 5-day price change of -0.27% and -17.33% over the past three months. RXRX shares are trading -24.54% year to date (YTD), with the 12-month market performance up to 8.45% higher. […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Hogging The Spotlight Today
Currently, there are 226.26M common shares owned by the public and among those 169.56M shares have been available to trade. The company’s stock has a 5-day price change of -15.25% and -24.77% over the past three months. RXRX shares are trading -23.94% year to date (YTD), with the 12-month market performance down to -0.66% lower. […]
